Noriaki Nakaya

Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis

Mitsuhiro Yokoyama, Hideki Origasa, Masunori Matsuzaki et al. · The Lancet · 2007 · 2.5K citations

Medicine, Cardiology, Pharmacology +12

Primary prevention of cardiovascular disease with pravastatin in Japan (MEGA Study): a prospective randomised controlled trial

Haruo Nakamura, Kikuo Arakawa, Hiroshige Itakura et al. · The Lancet · 2006 · 961 citations

Medicine, Cardiology, Preventive Medicine +9

Effects of EPA on coronary artery disease in hypercholesterolemic patients with multiple risk factors: Sub-analysis of primary prevention cases from the Japan EPA Lipid Intervention Study (JELIS)

Yasushi Saitō, Mitsuhiro Yokoyama, Hideki Origasa et al. · Atherosclerosis · 2008 · 319 citations

Medicine, Cardiology, Preventive Medicine +16

Large Scale Cohort Study of the Relationship Between Serum Cholesterol Concentration and Coronary Events With Low-Dose Simvastatin Therapy in Japanese Patients With Hypercholesterolemia

Masunori Matsuzaki, Toru Kita, Hiroshi Mabuchi et al. · Circulation Journal · 2002 · 261 citations · Full text

Medicine, Cardiology, Pharmacotherapy +14

Reduction in the Recurrence of Stroke by Eicosapentaenoic Acid for Hypercholesterolemic Patients

Kortaro Tanaka, Yuichi Ishikawa, Mitsuhiro Yokoyama et al. · Stroke · 2008 · 218 citations

Medicine, Pharmacotherapy, Preventive Medicine +17